---------- Forwarded message ---------
From: Genetic Engineering & Biotechnology News <gen@genmail.co>
Date: Fri, Feb 28, 2025 at 12:10 PM
Subject: AGBT 2025: GEN's Final Recap
To: <mxh5000@gmail.com>


TOP STORIES

Friday, February 28, 2025 

 

 
The Sun Sets on AGBT 2025: Final Report from Marco Island

The AGBT meeting has wrapped up its last day of talks, coffee hours, and socials. After a few whirlwind days, Julianna LeMieux, PhD, Deputy Editor in Chief joins Kevin Davies, PhD, Editorial Director, in a video chat to recap her last takeaways from the meeting. + MORE

 

 

Anti-inflammatory Drug Weakens Immune System’s Response to Brain Cancer

By analyzing single-cell and spatial transcriptomic data, scientists from McGill University, the Broad Institute, and elsewhere found evidence that a common anti-swelling drug used in brain cancer cases may suppress the immune system's efforts to combat cancerous cells. + MORE

 

 

Lilly Plans to More than Double U.S. Manufacturing Investment Since 2020 Exceeding $50 Billion

Three of the future sites will focus on manufacturing APIs, reshoring capabilities of small molecule chemical synthesis, and strengthening Lilly's supply chain. The fourth location will extend Lilly’s global parenteral manufacturing network for injectable therapies. + MORE

 

 

Extreme Heat Accelerates Biological Aging in Older Adults

Research suggests that greater exposure to extreme heat may accelerate epigenetic aging in older adults, raising new concerns about how climate change and heat waves could affect long-term health and aging at the molecular level. + MORE

 

 

Microbioreactors Small and Smart, Power More with Less

Shrinking in size but growing in might, microbioreactors are transforming biologics manufacturing. + MORE

 

 

SPONSORED

Discover integrated technologies for spatial multi-omics in this exclusive presentation. Whether your research focuses on RNA or protein, Bruker Spatial Biology offers comprehensive solutions—no compromises needed. Join us March 12th at 8am PST to learn more. Register Today

UPCOMING EVENTS

AGBT Debrief: What's Happening in NGS and Multiomics?

On TODAY's episode of GEN Live, we’ll give you a full AGBT breakdown. Experts from the NGS, single cell, and spatial fields join the show to review and dissect this year’s announcements. We’ll cover the latest research and novel technologies and parse the promises made by various companies—some old, some new. And we’ll explain what it means for the next year in omics. + MORE

 

 

Strategies for Successful Integration of Computational and Empirical Data for Protein Drug Discovery

In this GEN webinar, our subject matter experts, Dr. Lee Fader, Dr. Jeremy Dupaul-Chicoine, and Dr. Maximilian Ebert, will provide an overview of current methodologies and technological innovations for harmonizing heterogeneous data streams including molecular dynamics simulations, binding affinity predictions, and experimental validation data to drive breakthroughs in protein therapeutics. + MORE

 

 

Harnessing Single-Cell RNA Sequencing to Study Retinal Ganglion Cell Regeneration in Optic Neuropathies

In the first presentation of this GEN webinar, our expert speaker Devansh Agarwal will present results from a study and how the scientists generated RGC-like induced neurons in under a week by combining the pioneer factor NEUROG2 with RGC-specific TFs, and pre-patterning cells via BMP inhibition. + MORE

 

 

Genetic Engineering & Biotechnology News

Mary Ann Liebert, Inc., a Sage Company

140 Huguenot Street 

New Rochelle, NY 10801

You have received this email at mxh5000@gmail.com

Unsubscribe        Manage Preferences